Cite
HARVARD Citation
Simonsson, M. et al. (2016). CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients. BMC cancer. 16 (1), pp. 1-12. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Simonsson, M. et al. (2016). CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients. BMC cancer. 16 (1), pp. 1-12. [Online].